Acquisition - February 19, 2015
AZ Books UK–Sweden Flight
Beginning in March, AstraZeneca will pay for Scandinavian airline Sun Air to make the one-hour flight from Cambridge to Gothenburg’s Landvetter airport Monday to Thursday mornings, and return in the early evening, to link the company’s two research hubs. AstraZeneca has agreed to pay for 20 seats on each flight, but the remaining 12 will be open […]
Acquisition - February 18, 2015
Revenio, Tide Sign Agreement
Revenio Group Corporation has signed a license agreement with Tide Medical Oy for a patented invention to diagnose asthma. The agreement allows Revenio to use this invention to develop and commercialize products related to the screening, diagnosis, monitoring and treatment of asthma. It likelywill take several years before the products become commercially significant for the company. “Our […]
Acquisition - February 18, 2015
Cerner Acquires Siemens Health Services
Cerner Corp. has completed its acquisition of Siemens Health Services’ assets, client relationships and associates. Each organization expects to invest up to $50 million during an initial three-year term. The early focus of the alliance is on integrating diagnostics and therapeutics into the electronic health record. Cerner and the former Siemens business unit have a […]
Acquisition - February 18, 2015
AstraZeneca to Acquire Actavis’ Branded Respiratory Side in U.S., Canada
AstraZeneca plans to acquire the rights to Actavis’ branded respiratory business in the U.S. and Canada for an initial consideration of $600 million on completion and low single-digit royalties above a certain revenue threshold. When the transaction is finalized, AstraZeneca will own the development and commercial rights in the US and Canada to TudorzaTM PressairTM […]
Acquisition - February 10, 2015
Berlin-Chemie Marketing Emtrix
Berlin-Chemie AG, a member of the Menarini Group, has been granted the exclusive rights to market and sell Moberg Pharma’s Emtrix® in Russia and Ukraine. The extended distribution agreement builds on an existing collaboration between Moberg and Menarini, which resulted in a successful launch of Emtrix® in Italy. Product launches also have been initiated in […]
Acquisition - February 9, 2015
Isofol Seeks Marketing Partner
Isofol, a clinical stage pharmaceutical company based in Gothenburg, Sweden, has launched a global program to identify one or more strategic partners for commercialization of its Modufolin(R) chemotherapy asset. The Sage Group, which is based in Europe, the USA and Asia, has been appointed by Isofol to assist the company. Sage’s job is to identify […]
